Grown Rogue International (GRUSF) Share-based Compensation Growth (1y) (2016 - 2026)
Grown Rogue International (GRUSF) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -55.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.74% |
| Mar 31, 2026 | -89.21% |
| Dec 31, 2025 | -419.48% |
| Sep 30, 2025 | 911,452,470.55% |
| Jun 30, 2025 | -68.78% |
| Mar 31, 2025 | 2,455.68% |
| Jan 31, 2023 | 641.73% |
| Jan 31, 2022 | -91.57% |
| Oct 31, 2021 | 88.71% |
| Jul 31, 2021 | -124.21% |
| Apr 30, 2021 | -17.03% |
| Jan 31, 2021 | 384.15% |
| Oct 31, 2020 | 1,680.21% |
| May 31, 2018 | 126.23% |
| May 31, 2017 | -121.38% |
| Aug 31, 2016 | 863.47% |
| May 31, 2016 | 419.80% |